Clinical trial · Observational
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
NCT02765698CI-TRIAL-00032242terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the ability of PET/MRI (Positron Emission Tomography/Magnetic Resonance Imaging) to give physicians preoperative information about specific sites in the body that the endometrial cancer may be present. If the PET/MRI is accurate and successful in providing this information, then women in the future may be able to have less extensive surgery for their endometrial cancer after evaluation with PET/MRI.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Detection of distant metastasis of endometrial cancer by PET/MRI
- timeFrame
- one month
- description
- Preoperative PET/MRI will be read by a radiologist and compared to final pathologic evaluation of metastatic specimens in high risk endometrial cancer patients.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Biopsy-proven high-risk endometrial cancer (type 2 or grade 3 endometrioid histology) * BMI of at least 18.5 kg/m2 and less than 35 kg/m2 or axial diameter less than 25 cm * Patients who pass standard clinical MRI screening procedures * Receiving preoperative clinical evaluation at Mayo Clinic, Rochester, MN * Undergoing surgical staging and/or debulking at Mayo Clinic in Rochester, MN Exclusion Criteria: * Allergy to FDG or gadolinium * Contraindication to MRI scanning (Extreme claustrophobia preventing PET/MRI completion, patients who are unable to lay quietly for an additional 60 minutes of imaging * Known kidney disease or poor renal function * Pregnant
References
Publications (0)
Data not yet available
No reference posted for this study.